Tobacco divestment has been one of the most prominent approaches in European sustainable investment over the past years. A key stakeholder in the debate, the Tobacco Free Portfolios initiative, engages with institutional investors over the financial, social and health implications of tobacco use globally. More recently, investors are being challenged by the fast growth of the cannabis industry. While the global regulatory framework has come under review, proponents for deregulation contend that the positive impact on public health outweighs risks.
15:00 – Setting the scene
15:15 – Panel discussion
16:30 – Concluding Remarks
Dr. Rachel Melsom, MBBS, BS, Tobacco Free Portfolios
Rachel completed her first degree in Genetics at University College London in 1987 following which she pursued an extensive career in advertising, commercial media negotiations, founded an intellectual property consultancy, and developed interactive media programming for production in the USA. She is Director of Medical Matrix Consulting Ltd and has been advising independent medical businesses since 2010 on company structure, commercial development, partnership development, and business growth.
In 2008 she retrained as a Doctor and is currently practicing in the Department of Elderly Care at Worthing Hospital, one of only three acute trusts in the UK awarded the highest possible ‘Outstanding’ rating from CQC. Rachel combines this with her work across Europe for Tobacco Free Portfolios.
Rachel has presented globally to multiple Executive boards, at Investor Conferences in Sweden, Denmark, Holland, UK and France, a plenary panel at the PLSA in March 2018, and presented at the World Cancer Congress in October 2018.
She is also a Diplomat of the Global Charter, World Federation of Public Health Associations, a Trustee of the 4 Cancer Group, which provides respite to patients and families; and a Business Leader for ‘Founders 4 Schools’, a charity set up by Sherry Coutu, CBE, to improve the uptake of STEM subjects and increase employability of school leavers.
For more information on Tobacco Free portfolios, visit tobaccofreeportfolios.org
Jay Simpson, Associate Vice President, Sector Based Screening, ISS ESG
Jay has worked as an analyst focusing on corporate involvement in controversial business activities, ranging from traditional sin sectors to energy and extractive industries, for the past ten years. He has been following developments in the cannabis industry in line with the recent significant increase in investor interest. Relevant recent events include Cannabis webinars with RIA Canada and Brighttalk.
Oshni Arachchi, Associate Director, Head of Controversies & Global Norms Research, Sustainable & Responsible Investment Research, ISS ESG
Oshni leads the Controversies & Global Norms Research at ISS ESG, leading a team of expert analysts focusing on corporate adherence to global norms on human rights, labour standards, environmental protection and business malpractice.
Oshni joined Ethix SRI Advisors in 2012 and for the past seven years has assisted institutional investors globally in implementing their policies and solutions for sustainable and responsible investment. Ethix SRI Advisors has been part of ISS since 2015.
Oshni is also an expert in the area of international human rights and labour rights law and has previously worked for international NGOs, research organizations and the United Nations.
ISS-ethix, Fleminggatan 7, floor 5, 112 26 Stockholm